Cargando…

Outcome measures of phase III anticancer drug trials in China

Detalles Bibliográficos
Autores principales:	Guo, Lanwei, Huang, Huiyao, Yu, Yue, Wang, Jun, Wang, Le, Wang, Shuhang, Wu, Dawei, Fang, Yuan, Jiang, Ning, Zhang, Shaokai, Tang, Yu, Li, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278717/ https://www.ncbi.nlm.nih.gov/pubmed/37026851 http://dx.doi.org/10.1097/CM9.0000000000002264

Ejemplares similares

Evolution of Early-Phase Anticancer Drug Investigations in China
por: Wang, Shuhang, et al.
Publicado: (2022)

Availability and Affordability of Oncology Drugs in 2012-2021 in China and the United States
por: Huang, Huiyao, et al.
Publicado: (2022)

Unfair older patients restriction in cancer drug trials in mainland China and corresponding solution
por: Huang, Huiyao, et al.
Publicado: (2023)

Seven-year exclusivity and beyond for drugs of rare diseases in China
por: Jiang, Yale, et al.
Publicado: (2023)

The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trials
por: Wu, Dawei, et al.
Publicado: (2022)

Association between germ-line HLA and immune-related adverse events
por: Jiang, Ning, et al.
Publicado: (2022)

Targeting rare tumors: new focus for clinical research in China
por: Wang, Shuhang, et al.
Publicado: (2022)

Comprehensive Genomic Profiling of Rare Tumors: Routes to Targeted Therapies
por: Wang, Shuhang, et al.
Publicado: (2020)

Expenditure and Financial Burden for Stomach Cancer Diagnosis and Treatment in China: A Multicenter Study
por: Zhang, Kai, et al.
Publicado: (2020)

Unblinding at disease progression in double-blinded randomized controlled cancer drug clinical trials: A controversy requires more attention
por: Dawei, Wu, et al.
Publicado: (2022)

Fruit fly for anticancer drug discovery and repurposing
por: Nainu, Firzan, et al.
Publicado: (2023)

Clinical development of mRNA therapies against solid tumors
por: Wu, Dawei, et al.
Publicado: (2023)

Current Research of Chlamydial Infection Diseases in China
por: Li, Xue, et al.
Publicado: (2018)

Reply to ‘Enhancing a phase measurement by sequentially probing a solid-state system'
por: Liu, Gang-Qin, et al.
Publicado: (2016)

Comments on: a phase 1/2a, dose-escalation, safety and preliminary efficacy study of oral therapeutic vaccine in subjects with cervical intraepithelial neoplasia 3
por: Zhang, Ning, et al.
Publicado: (2020)

Inadequate Evidence to Support Phase III Studies of Albumin in Severe Malaria
por: Woodrow, Charles J, et al.
Publicado: (2007)

Phase III Trial of Albumin in Malaria Still Lacks Scientific Justification
por: Woodrow, Charles J, et al.
Publicado: (2007)

The blood virome of 10,585 individuals from the ChinaMAP
por: Guo, Jia, et al.
Publicado: (2022)

China's COVID-19 reopening measures—warriors and weapons
por: Huang, Shujie, et al.
Publicado: (2023)

Platform study of genotyping-guided precision medicine for rare solid tumours: a study protocol for a phase II, non-randomised, 18-month, open-label, multiarm, single-centre clinical trial testing the safety and efficacy of multiple Chinese-approved targeted drugs and PD-1 inhibitors in the treatment of metastatic rare tumours
por: Wang, Shuhang, et al.
Publicado: (2021)

Circadian rhythms of melatonin, cortisol, and clock gene expression in the hyperacute phase of wake-up stroke: study design and measurement
por: Zhang, Xian-Xian, et al.
Publicado: (2020)

Focus on anticancer therapy-induced cardiotoxicity from the perspective of oncologists
por: Liu, Binliang, et al.
Publicado: (2022)

Remote video lecture education improves anesthesiology residency training in Tibet of China
por: Li, Xu, et al.
Publicado: (2020)

Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
por: Wang, Shuhang, et al.
Publicado: (2022)

Prostate cancer and hypofractionation: reflections on recent randomised phase III clinical trial results
por: Dearnaley, David, et al.
Publicado: (2017)

Problematic Analysis and Inadequate Toxicity Data in Phase III Apatinib Trial in Gastric Cancer
por: Zhang, Sheng
Publicado: (2016)

Evolution of drug regulations and regulatory innovation for anticancer drugs in China
por: Liu, Yang, et al.
Publicado: (2022)

Geriatric drug trials on solid tumor are scarce worldwide
por: Huang, Huiyao, et al.
Publicado: (2023)

Medical education reforms in China
por: Qiao, Jie, et al.
Publicado: (2023)

Efficacy and safety of apremilast in patients with moderate‐to‐severe plaque psoriasis of the scalp: results up to 32 weeks from a randomized, phase III study
por: Van Voorhees, A.S., et al.
Publicado: (2021)

Bronchiectasis severity assessment on predicting hospital readmission: a single-center prospective cohort study
por: Wang, Xiao-Yue, et al.
Publicado: (2021)

Unique meteorological characteristics in the upper gastrointestinal bleeding by different etiologies in Beijing Area, China
por: Yuan, Yue, et al.
Publicado: (2021)

Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
por: Bos, Eelke M., et al.
Publicado: (2023)

Adverse events of PD-(L)1 inhibitors plus anti-VEGF(R) agents compared with PD-(L)1 inhibitors alone for cancer patients: a systematic review and meta-analysis
por: Tang, Qiyu, et al.
Publicado: (2023)

Effectiveness evaluation of organized screening for esophageal cancer: a case-control study in Linzhou city, China
por: Chen, Qiong, et al.
Publicado: (2016)

Immunotherapy in patients with metastatic castration-resistant prostate cancer: a meta-analysis of data from 7 phase III studies and 3 phase II studies
por: Zhang, Anqiang, et al.
Publicado: (2022)

Phase III Trials Required to Resolve Clinical Equipoise over Optimal Fluid Management in Children with Severe Malaria
por: Maitland, Kathryn, et al.
Publicado: (2007)

Asthma treatment adherence and related factors in Shanghai, China
por: Du, Juan, et al.
Publicado: (2021)

Demographic Characterization of Patients Enrolled in the China Pituitary Disease Register Network
por: Feng, Ming, et al.
Publicado: (2018)

Incidence and mortality of gastric cancer in 2018 and their trends from 2010 to 2018 in Henan Province, China: results from a provincial population-based cancer registry
por: Chen, Qiong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2fq4fks7kv70dnmuh8t27tfud9